Goodwin C, Raftery E, Goldberg A, Skeggs H, Till A, Martin C
Antimicrob Agents Chemother. 1974; 6(3):338-46.
PMID: 15830485
PMC: 444649.
DOI: 10.1128/AAC.6.3.338.
Brogden R, Carmine A, Heel R, Morley P, Speight T, Avery G
Drugs. 1981; 22(5):337-62.
PMID: 7037354
DOI: 10.2165/00003495-198122050-00001.
Sato K, Matsuura Y, Inoue M, Mitsuhashi S
Antimicrob Agents Chemother. 1982; 22(4):579-84.
PMID: 6983857
PMC: 183796.
DOI: 10.1128/AAC.22.4.579.
Crosby M, Gump D
Antimicrob Agents Chemother. 1982; 22(3):398-405.
PMID: 6291451
PMC: 183756.
DOI: 10.1128/AAC.22.3.398.
Brown J, Del Bene V, Collins C
Antimicrob Agents Chemother. 1981; 19(2):248-52.
PMID: 6214986
PMC: 181402.
DOI: 10.1128/AAC.19.2.248.
In vitro activity of cefbuperazone compared with that of other new beta-lactam agents against anaerobic gram-negative bacilli and contribution of beta-lactamase to resistance.
Del Bene V, Carek P, Twitty J, Burkey L
Antimicrob Agents Chemother. 1985; 27(5):817-20.
PMID: 3874597
PMC: 180158.
DOI: 10.1128/AAC.27.5.817.
Enzymatic inactivation of aztreonam by faecal enzyme preparations from healthy volunteers.
Welling G, Groen G, de Vries-Hospers H, Van Der Waaij D
Infection. 1987; 15(3):188-91.
PMID: 3610324
DOI: 10.1007/BF01646046.
Susceptibility of anaerobes to cefoxitin and other cephalosporins.
Tally F, Jacobus N, Bartlett J, Gorbach S
Antimicrob Agents Chemother. 1975; 7(2):128-32.
PMID: 1137364
PMC: 429091.
DOI: 10.1128/AAC.7.2.128.
In vivo protection of Fusobacterium necrophorum from penicillin by Bacteroides fragilis.
Hackman A, Wilkins T
Antimicrob Agents Chemother. 1975; 7(5):698-703.
PMID: 1041218
PMC: 429206.
DOI: 10.1128/AAC.7.5.698.
Beta-lactamase activity in anaerobic bacteria.
Weinrich A, Del Bene V
Antimicrob Agents Chemother. 1976; 10(1):106-11.
PMID: 984742
PMC: 429697.
DOI: 10.1128/AAC.10.1.106.
Cefoxitin resistance to beta-lactamase: a major factor for susceptibility of bacteroides fragilis to the antibiotic.
Darland G, Birnbaum J
Antimicrob Agents Chemother. 1977; 11(4):725-34.
PMID: 856025
PMC: 352058.
DOI: 10.1128/AAC.11.4.725.
Cefoxitin: clinical evaluation in thirty-eight patients.
Heseltine P, Busch D, Meyer R, Finegold S
Antimicrob Agents Chemother. 1977; 11(3):427-34.
PMID: 855997
PMC: 352002.
DOI: 10.1128/AAC.11.3.427.
Anaerobic bacteria: evaluation of disc susceptibility to four cephalosporins.
Dubois J, Pechere J
Infection. 1978; 6(6):266-70.
PMID: 730395
DOI: 10.1007/BF01641985.
Comparative in vitro activity of newer cephalosporins against anaerobic bacteria.
Chow A, Bednorz D
Antimicrob Agents Chemother. 1978; 14(5):668-71.
PMID: 727759
PMC: 352532.
DOI: 10.1128/AAC.14.5.668.
Susceptibility to beta-lactam antibiotics and production of beta-lactamase in Bacteroides fragilis.
Olsson B, Dornbusch K, Nord C
Med Microbiol Immunol. 1977; 163(3):183-94.
PMID: 243112
DOI: 10.1007/BF02126677.
Purification and properties of beta-lactamase from Bacteroides fragilis.
Britz M, Wilkinson R
Antimicrob Agents Chemother. 1978; 13(3):373-82.
PMID: 45494
PMC: 352248.
DOI: 10.1128/AAC.13.3.373.
Characterization of anaerobic gram-negative bacilli by using rapid slide tests for beta-lactamase production.
Bourgault A, Rosenblatt J
J Clin Microbiol. 1979; 9(6):654-6.
PMID: 41001
PMC: 275374.
DOI: 10.1128/jcm.9.6.654-656.1979.
Chromogenic cephalosporin spot test to detect beta-lactamase in clinically significant bacteria.
Montgomery K, Raymundo Jr L, Drew W
J Clin Microbiol. 1979; 9(2):205-7.
PMID: 34624
PMC: 272992.
DOI: 10.1128/jcm.9.2.205-207.1979.
Beta-Lactamase activity in strains of Bacteroides melaninogenicus and Bacteroides oralis.
Salyers A, Wong J, Wilkins T
Antimicrob Agents Chemother. 1977; 11(1):142-6.
PMID: 13705
PMC: 351933.
DOI: 10.1128/AAC.11.1.142.
Formation of beta-lactamase in Bacteroides fragilis: cell-bound and extracellular activity.
Olsson B, Nord C, Wadstrom T
Antimicrob Agents Chemother. 1976; 9(5):727-35.
PMID: 7997
PMC: 429612.
DOI: 10.1128/AAC.9.5.727.